Pyrazinamide Resistance: A Major Cause of Switching Shorter to Longer Bedaquiline-based Regimens in Multidrug-resistant Tuberculosis Patients
Background: All-oral regimens, including bedaquiline, are now standard in shorter treatment regimens (STRs) for multidrug-resistant tuberculosis (MDR-TB). Resistance or intolerance to drugs in STR often necessitates a switch to longer treatment regimens (LTRs). This study aims to identify the factor...
Saved in:
| Main Authors: | Oki Nugraha Putra, Nur Indah, Telly Purnamasari, Adi Larasanti |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2024-12-01
|
| Series: | International Journal of Mycobacteriology |
| Subjects: | |
| Online Access: | https://journals.lww.com/10.4103/ijmy.ijmy_164_24 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Shorter versus longer-duration antibiotic treatments for immunocompetent patients with bloodstream infections: a systematic review and meta-analysisResearch in context
by: Ming Liu, et al.
Published: (2025-08-01) -
Efficacy and Adverse Event Profile in Patients Receiving “Shorter Oral Bedaquiline-containing Multidrug-resistant/Rifampicin-resistant Tuberculosis Regimen” in a Tertiary Care Hospital in Eastern India
by: Hindol Mondal, et al.
Published: (2025-07-01) -
Adverse Drug Reactions in Multidrug-resistant Tuberculosis Patients on Longer Bedaquiline-based Regimen at a Tertiary Care Center in Mumbai
by: Abhishek Saini, et al.
Published: (2025-07-01) -
Operational research as a mechanism to improve treatment outcomes for drug-resistant TB in the WHO European Region
by: G.B. Migliori, et al.
Published: (2024-03-01) -
Treatment success using novel and adapted treatment regimens in registered DR-TB children in Dushanbe, Tajikistan, 2013-2019
by: Bobojon Pirmahmadzoda, et al.
Published: (2021-09-01)